Screener
Organogenesis Holdings Inc. ORGO Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Organogenesis Holdings Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338049
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accounts payable | (1,398) | 1,637 |
| Accrued expenses and other current liabilities | (29,281) | (13,886) |
| Other liabilities | 590 | 34 |
| Net cash used in operating activities | (10,526) | (52,808) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (4,246) | (7,264) |
| Net cash used in investing activities | (4,246) | (7,264) |
| Cash flows from financing activities: |
Item 1. Unaudited Condensed Consolidated Financial Statements.
FAQ
- What is Organogenesis Holdings Inc.'s operating cash flow?
- Organogenesis Holdings Inc. (ORGO) reported operating cash flow of -$31.65M in Q2 2026.
- How has Organogenesis Holdings Inc.'s operating cash flow changed year-over-year?
- Organogenesis Holdings Inc.'s operating cash flow increased by 3.7% year-over-year, from -$32.87M to -$31.65M.
- What is the long-term trend for Organogenesis Holdings Inc.'s operating cash flow?
- Over 3 years (2021 to 2024), Organogenesis Holdings Inc.'s operating cash flow has grown at a -38.8% compound annual growth rate (CAGR), from $61.98M to $14.21M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Organogenesis Holdings Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude